Authors’ contributions {31b}
HB and ES drafted the manuscript and HB will analyse the clinical trial data. ES, JB, GM, MM, KR, LA, RB, JA, SS, NP and PK participated in the initial design of this clinical trial with HB and CS contributing to amendments. KM, ES and HB developed the software for use in the intervention. CS will oversee the clinical implementation of the Breathe Well technology and will assist HB in collecting the trial data. BZ, FB and HB developed the analysis tools for the trial data. HB and PK developed the statistical methodology for the clinical trial. All authors read and approved the final manuscript.